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A B S T R A C T
Background
Late-onset infection is the most common serious complication associated with hospital care for newborn infants. Because confirming
the diagnosis by microbiological culture typically takes 24 to 48 hours, the serum level of the inflammatory marker C-reactive protein
(CRP) measured as part of the initial investigation is used as an adjunctive rapid test to guide management in infants with suspected
late-onset infection.
Objectives
To determine the diagnostic accuracy of serum CRP measurement in detecting late-onset infection in newborn infants.
Search methods
We searched electronic databases (MEDLINE, Embase, and Science Citation Index to September 2017), conference proceedings,
previous reviews, and the reference lists of retrieved articles.
Selection criteria
We included cohort and cross-sectional studies evaluating the diagnostic accuracy of serum CRP levels for the detection of late-onset
infection (occurring more than 72 hours after birth) in newborn infants.
Data collection and analysis
Two review authors independently assessed eligibility for inclusion, evaluated the methodological quality of included studies, and
extracted data to estimate diagnostic accuracy using hierarchical summary receiver operating characteristic (SROC)models. We assessed
heterogeneity by examining variability of study estimates and overlap of the 95% confidence interval (CI) in forest plots of sensitivity
and specificity.
Main results
The search identified 20 studies (1615 infants). Most were small, single-centre, prospective cohort studies conducted in neonatal units
in high- or middle-income countries since the late 1990s. Risk of bias in the included studies was generally low with independent
assessment of index and reference tests. Most studies used a prespecified serum CRP threshold level as the definition of a ’positive’ index
test (typical cut-off level between 5 mg/L and 10 mg/L) and the culture of a pathogenic micro-organism from blood as the reference
standard.
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At median specificity (0.74), sensitivity was 0.62 (95% CI 0.50 to 0.73). Heterogeneity was evident in the forest plots but it was not
possible to conduct subgroup or meta-regression analyses by gestational ages, types of infection, or types of infecting micro-organism.
Covariates for whether studies used a predefined threshold or not, and whether studies used a standard threshold of between 5 mg/L
and 10 mg/L, were not statistically significant.
Authors’ conclusions
The serumCRP level at initial evaluation of an infant with suspected late-onset infection is unlikely to be considered sufficiently accurate
to aid early diagnosis or select infants to undergo further investigation or treatment with antimicrobial therapy or other interventions.
P L A I N L A N G U A G E S U M M A R Y
C-reaction protein for diagnosing infection in newborn infants
Review question
We reviewed studies that assessed whether measuring the blood level of C-reactive protein (CRP) helped to make an earlier diagnosis
of serious infections in newborn infants.
Background
Newborn infants, especially sick or preterm infants, are at risk of developing severe infections (such as bloodstream infections) during
their stay on neonatal units. Infections are often difficult to diagnose early with certainty, and quick tests such as measuring the blood
level of a protein that responds to infection (called CRP) are sometimes used to help make an earlier diagnosis. We aimed to assess the
evidence for the accuracy of this test.
Study characteristics
We found 20 studies that assessed the accuracy of measuring the blood level of CRP to diagnose infections in newborn infants. These
studies were similar enough to justify a combined analysis of their findings.
Key results
The combined analysis indicated that a positive CRP test correctly identified infants with infection about six times out of 10.
Conclusion
Measuring the blood level of CRP is not sufficiently accurate to help early diagnosis of infection in newborn infants.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Question: Should serum CRP levels be used to diagnose late-onset infect ion in newborn infants?
Study design: prospect ive or retrospect ive cohorts and cross-sect ional studies. We excluded case reports and studies of case-control design
Sensitivity at median specificity: 0.62 (95%CI 0.50 to 0.73)
Median specificity: 0.74
of studies (infants): 20 (1615)
of true positives: 617
of true negatives: 998
Outcome Factors that may decrease certainty of evidence Effect per 1000 infants tested Test accuracy
quality of evi-
dence
Risk of bias Indirectness Inconsistency Imprecision Publication bias Pretest probabil-
ity of 20%
Pretest probabil-
ity of 40%
Pretest probabil-
ity of 60%
True positives
(infants with
late-onset in-
fect ion)
Not serious Not serious Serious Not serious None 124 (100 to 146) 248 (200 to 292) 372 (300 to 438) ⊕⊕⊕©
Moderate
False negatives
(infants incor-
rect ly classif ied
as not hav-
ing late-onset
infect ion)
76 (54 to 100) 152 (108 to 200) 228 (162 to 300) -
True negatives
(infants with-
out late-onset
infect ion)
Not serious Not serious Serious Not serious None 592 (- to -) 444 (- to -) 296 (- to -) ⊕⊕⊕©
Moderate
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False positives
(infants incor-
rect ly classif ied
as having late-
onset infect ion)
208 (- to -) 156 (- to -) 104 (- to -) -
CI: conf idence interval.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
4
C
-re
a
c
tiv
e
p
ro
te
in
fo
r
d
ia
g
n
o
sin
g
la
te
-o
n
se
t
in
fe
c
tio
n
in
n
e
w
b
o
rn
in
fa
n
ts
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
9
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
B A C K G R O U N D
Target condition being diagnosed
Late-onset infection in newborn infants
Late-onset infection (occurring more than 72 hours after birth) is
the most common serious complication associated with intensive
care for newborn infants (McGuire 2004). The incidence of late-
onset infection is inversely related to gestational age at birth and
has increased as survival rates for preterm infants have improved
(van den Hoogen 2010). About 20% of very preterm infants ex-
perience an episode of late-onset infection reflecting their level
and duration of exposure to invasive procedures and intensive care
(Vergnano 2011; Berrington 2012; Oeser 2014). Central line-as-
sociated bloodstream infection (CLABSI) is a major subtype of
late-onset infection that is associated with the use of central vas-
cular catheters (CVC) to deliver drugs, fluids, or parenteral nutri-
tion for newborn infants (Benjamin 2001; Butler-O’Hara 2012;
Shalabi 2015).Other putative risk factors include receipt of broad-
spectrum antibiotics and of histamine type 2-receptor antagonists
(Shane 2014; Tsai 2014a). However, interunit variation in the in-
cidence of late-onset infection is not fully explained by case-mix
and may relate to uptake and use of care or infection control prac-
tices (Wong 2012).
Microbiology of late-onset infection
The common causes of late-onset infections in sick or preterm
newborn infants are coagulase-negative staphylococci, other
Gram-positive cocci (Staphylococcus aureus (S aureus), enterococci),
Gram-negative bacilli (mainly enteric bacilli), and fungi (predom-
inantly Candida species) (Stoll 2003; Zaidi 2005; Gordon 2006;
Muller-Pebody 2011;Hornik 2012; Shane 2013). Preterm infants,
particularly very preterm infants, with late-onset infection have
a higher risk of mortality and a range of important morbidities
including bronchopulmonary dysplasia, necrotising enterocolitis,
retinopathy of prematurity, and need for intensive care and pro-
longed hospitalisation than comparable infants without infection
(Shah 2014). Late-onset infection is associated with higher rates of
adverse neurodevelopmental outcomes including visual, hearing,
and cognitive impairment, and cerebral palsy (Stoll 2004; Bassler
2009).
Antimicrobial resistance
Delayed treatment of bacterial or fungal late-onset infections may
increase the risk of morbidity and mortality in newborn infants.
However, because clinical signs of infection in neonates can be
non-specific, empirical treatment of all infants with suspected in-
fection will result in the administration of unnecessary courses
of antibiotics (Dong 2015). Such widespread use, particularly of
broad-spectrum antibiotics, is associated with accelerated selec-
tive pressure and the emergence of drug resistance through mech-
anisms such as extended-spectrum B-lactamase production (de
Man 2000; Muller-Pebody 2011; Tsai 2014b).
Index test(s)
Diagnosing late-onset infection in preterm infants
Given the difficulty in establishing an early diagnosis based on
clinical features alone, and the high level of associated morbidity
andmortality, several ’biomarkers’ of infection have been proposed
and adopted as tests to determine whether late-onset infection is
more or less likely in newborn infants in whom it is suspected
(Shane 2013; Gilfillan 2017). The most commonly used and es-
tablished of these is the serum level of C-reactive protein (CRP).
CRP is an acute-phase reactant synthesised by hepatocytes in re-
sponse to inflammatory cytokines, particularly interleukin (IL)-
6, generated by white blood cells reacting to microbial pyrogens
such as lipopolysaccharide (Steel 1994). The major physiological
role of serum CRP is to bind to microbial polysaccharides and
immune complexes and activate the classical complement cascade
(Volanakis 2001).
CRP levels can be measured in laboratories within about one hour
using a very small volume of serum (20 µL). Serum levels are
usually very low (undetectable at the lower limits of sensitivity
of standard laboratory analysis, typically 5 mg/L to 10 mg/L),
but rise to detectable concentrations following an infectious or
inflammatory stimulus over 12 to 24 hours. In infants exposed
to infectious inflammatory stimuli, serum CRP levels may rise
by more than 100-fold, declining with a half-life of about 18
to 24 hours when the stimulus ceases (Ehl 1999). Many non-
infectious inflammatory stimuli including chemical or physical
irritation such as extravasation of hypertonic or irritant solutions
may also cause serumCRP levels to rise in newborn infants (Hofer
2013).
Clinical pathway
The use of biomarkers in general, and CRP in particular, as ad-
junctive diagnostic tests in neonatal care settings occurs within
three broad clinical contexts.
• Diagnosing infection: the serum CRP level is used to
determine whether late-onset infection is less or more likely in
infants in whom there is a clinical suspicion based on signs such
as unstable temperature, respiratory instability (apnoea,
desaturation), enteral feed intolerance, or general concern that
the infant appears unwell.
• Screening for infection: serum CRP levels are monitored at
intervals to detect infants in whom an infection may be
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developing before being clinically suspected. In clinical practice,
this approach is usually targeted to infants considered to be at an
elevated risk of acquiring an infection because of specific risk
factors such as the presence of a CVC.
• Monitoring response to treatment: serial measurement of
serum CRP is also used to track the course of late-onset infection
and assess the response to antimicrobial treatment, including
acting as indicator for stopping antibiotics when a previously
elevated serum CRP level has returned to ’normal’ (Ehl 1997).
This review addressed the diagnostic accuracy of the serum CRP
level in the first scenario (i.e. diagnosing infection) only. As de-
tection of an elevated serum CRP level (index test) would be used
to trigger application of the reference test in the other scenarios,
it is not possible to measure diagnostic accuracy.
Prior test(s)
Serum CRP is typically measured at the initial assessment of an
infant with suspected late-onset infection, usually alongside other
tests including laboratory culture of a blood sample to culture
micro-organisms (’blood culture’).
Role of index test(s)
Because the microbiological culture of a potentially pathogenic
organism (the reference standard) from a blood sample takes about
24 to 48 hours to complete, the purpose of measuring the serum
CRP level is to help make a more immediate assessment of the
overall likelihood that an infant is truly infected. In current clinical
practice, the main aims are to help decide (Pammi 2015):
• whether the likelihood of infection justifies further invasive
tests (such as examination of the cerebrospinal fluid (CSF) to
diagnose or exclude meningitis);
• whether it is appropriate to administer antibiotics or other
antimicrobial therapy immediately;
• whether other interventions such as removing a CVC that is
potentially a nidus for infection are justified.
Alternative test(s)
Several other biomarkers of infection or inflammation have been
evaluated in neonatal care settings and different areas of clinical
practice. These include haematological indices (peripheral total
white blood cell count, neutrophil count, and immature-to-total
neutrophil ratio (I/T-ratio); serum procalcitonin; the acute phase
protein serum amyloid A; several proinflammatory cytokines such
as IL-6, IL-8, and tumour necrosis factor (TNF); and other mark-
ers of immune activation (Fowlie 1998; Malik 2003). These alter-
native biomarkers are generally more expensive to measure than
CRP and are not as well established in routine practice (Hedegaard
2015). More recent developments include biomarkers based on
detectingmicrobial DNA (’molecular biomarkers’) and computer-
based integration of physiological markers such as heart rate vari-
ability to detect infants with a developing infection (Dong 2015).
Rationale
SerumCRP level may be a useful adjunctive diagnostic biomarker
for late-onset infection in newborn infants if it has acceptable levels
of accuracy. Currently, in the absence of robust evidence to inform
guideline or protocol development, clinical practice varies greatly
with regard to the role of serum CRP in diagnostic algorithms
for late-onset infection (Dong 2015; Pammi 2015). Most studies
examining the accuracy of CRP and other biomarkers of late-onset
infection have been conducted in single centres and, therefore, are
limited by the small sample size. A systematic review to identify,
quality-appraise, and synthesise the data in meta-analyses could
help clarify the evidence-base to inform policy and practice, and
future research.
O B J E C T I V E S
To determine the diagnostic accuracy of serumCRPmeasurement
in detecting late-onset infection in newborn infants.
Secondary objectives
To investigate heterogeneity of test accuracy in the included studies
(see: Investigations of heterogeneity).
Possible sources of heterogeneity include between-study variation
in the demographic characteristics of study participants (e.g. term
versus preterm infants), use of different cut-off values of serum
CRP levels used to define a positive test (e.g. 5 mg/L to 10 mg/
L versus higher values), and subtypes of late-onset infection (e.g.
CLABSI versus non-CLABSI).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Cohort and cross-sectional studies evaluating the diagnostic accu-
racy of serum CRP for the detection of late-onset infection (more
than 72 hours after birth) in newborn infants were eligible for
inclusion. Studies using CRP along with another biomarker were
eligible provided data on the diagnostic performance of CRP alone
could be extracted. We have not included case-control studies as
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this design is unlikely to allow valid assessment of diagnostic test
accuracy in this clinical context.
For inclusion in meta-analyses, a study of diagnostic accuracy
needed to provide sufficient data to construct the ’2×2’ diagnostic
table (true positive, false positive, true negative, and false negative)
showing the cross-classification of disease status (microbiologically
confirmed infection) and test outcome (serumCRP level). If study
reports did not provide data sufficient to construct the diagnostic
table, we contacted the corresponding authors to seek the missing
data, where appropriate and practicable.
Studies investigating early-onset infection (diagnosed before 72
hours postnatally) were not eligible. Studies investigating both
early- and late-onset infection were eligible provided separate data
could be extracted for late-onset infection. If not reported, we
contacted the corresponding author to request unpublished data
on late-onset infection if the article indicated that these data may
have been collected.
Participants
Hospitalised newborn infants aged more than 72 hours until the
first discharge home after birth were eligible. We excluded studies
where the participants were young infants cared for at home or in
another community setting who then presented to a primary or
secondary healthcare facility with possible infection.
We considered infants across all gestational ages and planned to
conduct subgroup analyses by gestational age: term (greater than
37 weeks’ gestation), preterm (less than 37 weeks’ gestation), and
very preterm (less than 32 weeks’ gestation).
Index tests
Serum CRP level: we accepted the threshold for the index test as
defined by individual studies (expected typically to be in the range
5 mg/L to 10 mg/L).
Target conditions
Microbiologically confirmed late-onset infection (more than 72
hours after birth) including bacteraemia, fungaemia, meningitis,
osteomyelitis, septic arthritis, and peritonitis.
We excluded data on the diagnostic accuracy of CRP in infants
with ’suspected’ or ’probable’ infection (also referred to as ’clinical
sepsis’), that is, infection suspected because of clinical or laboratory
features and findings but not confirmed bymicrobiological culture
of pathogens. If studies reported data on infants with clinical sep-
sis as well as ’microbiologically confirmed’ infection, we extracted
the data according to microbiological culture status rather than
according to the authors’ definition of clinical sepsis. We planned
to exclude studies of infants diagnosed with pneumonia based on
clinical and radiological features even if supported by microbio-
logical culture of bacteria or fungi from endotracheal aspirates.
Although it may be argued that excluding suspected or probable
infection is inconsistent with normal clinical practices, the lack
of a widely acceptable and reliable clinical definition makes it less
valid to incorporate as an eligibility criterion for this review. We
contacted the corresponding author to request unpublished data
as necessary, where appropriate and practicable.
Reference standards
Infection diagnosed more than 72 hours after birth, confirmed by
culture from a normally sterile site: CSF, blood (from peripheral
sites, not from indwelling catheters), bone or joint, peritoneum,
pleural space, or findings on autopsy examination consistent with
microbial infection (microbiological confirmation or morpholog-
ical findings consistent with infection). Because ’false-positive’ re-
sults due to skin contaminants were possible, we excluded cases
where infection was attributed to diphtheroids, micrococci, propi-
onibacteria, or a mixedmicrobial flora (where data were available).
We planned to examine specific infections with the following or-
ganisms, if data were available: coagulase-negative staphylococci,
other bacteria (Gram-negative bacilli, S aureus, enterococci), and
fungi.
We did not include urinary tract infections because these are un-
common in newborn infants unless associated with bacteraemia
and because diagnosis requires urine obtained by sterile urethral
catheterisation or suprapubic bladder tap which are sampling
methods employed rarely in current practice.
We excluded any studies in which the reference standard incor-
porated the index test, that is, ’infection’ was defined as a positive
microbiological culture and raised serum CRP level.
Search methods for identification of studies
We used the standard Cochrane Neonatal search strategy adapted
for studies of diagnostic test accuracy (Beynon 2013).
Electronic searches
We searched MEDLINE, Embase, and Science Citation Index:
see Appendix 1. The initial search was carried out in May 2015
and updated in September 2017.
Searching other resources
We examined the reference lists of all studies identified as poten-
tially relevant.
We searched the abstracts from the annual meetings of the Pedi-
atric Academic Societies (1993 to 2017), the European Society
for Pediatric Research (1995 to 2017), the UK Royal College of
Paediatrics and Child Health (2000 to 2017), and the Perinatal
Society of Australia and New Zealand (2000 to 2017). Studies
reported only as abstracts were eligible if sufficient information
was available from the report or from contact with the authors to
fulfil the inclusion criteria.
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Data collection and analysis
Two review authors screened all titles and abstracts identified by
our search strategy for relevance to the inclusion criteria of this re-
view as detailed in Criteria for considering studies for this review.
All references were managed in an EndNote library and then ex-
ported to Covidence for study selection.
Selection of studies
We retrieved the full text of all identified articles that were deemed
relevant to the review and evaluated them against our inclusion
eligibility. Two review authors independently assessed studies for
eligibility for inclusion. We resolved disagreements by discussion
with a third review author.
Data extraction and management
One review author extracted the following data.
• Author and year of publication.
• Study design including sample size, type of recruitment
(prospective or retrospective).
• Study population characteristics and the clinical context in
which the test was evaluated.
• Definition of reference standard.
• CRP threshold used.
• Information regarding quality assessment items of the
Quality Assessment of Diagnostic Accuracy Studies-2
(QUADAS-2) tool (Assessment of methodological quality).
• Data to enable derivation of 2×2 tables of the number of
true positives, false positives, false negatives, and true negatives.
One review author extracted data and a second review author
checked them. We resolved any discrepancies by discussion and
arbitration by a third review author if required.
When contacting corresponding authors to request additional data
or information, we took a pragmatic approach tomanage resources
sensibly. We attempted to contact authors of reports published
since 2005 by email only. If there was no contact email address
after a reasonable amount of online research, we did not attempt
to contact authors by other means such as telephone or post. If our
email remained unanswered after one week, we sent one follow-up
email. If data could not be obtained after this, a team decision was
made to exclude the study. Authors of studies published before
2005 were only contacted if an email address was provided as part
of the publication. We reported all excluded studies, with reasons
for exclusion given (Characteristics of excluded studies table).
Assessment of methodological quality
We assessed methodological quality of each included study fol-
lowing guidance from the Cochrane Screening and Diagnostic
Test Methods Group, which is adapted from the QUADAS-2 tool
(Whiting 2011: see Table 1). The four domains assessed for risk of
bias were patient selection, index test, reference standard, and flow
and timing. Applicability concerns were assessed in the first three
domains. In each domain, we answered the signalling questions
with ’Yes’, ’No’, or ’Unclear’ and for each domain judged the risk
of bias as ’Low’, ’High’, or ’Unclear’ risk.
We excluded studies at high risk of incorporation bias, that is,
those studies in which a raised CRP level was part of the diagnostic
criteria for infection.
One review author assessed study quality, which a second review
author checked. We resolved any disagreements by discussion,
with referral to a third review author as necessary.
We summarised overall quality of evidence using GRADE
methodology recommended for diagnostic tests (Singh 2012).
Statistical analysis and data synthesis
We constructed 2×2 diagnostic tables for all studies based on di-
chotomous data from the reference standard (infected or not in-
fected) and index test (the cut-off level for serum CRP for a posi-
tive result (suggestive or diagnostic of late-onset infection) as de-
fined by each study). Only the test taken at the same time as the
reference standard was used. We created forest plots with 95%
confidence intervals (CI) for sensitivity and specificity for each
study using Review Manager 5 (Review Manager 2014).
Since reported threshold levels for a positive test differed across
studies, we fitted the data in a hierarchical summary receiver oper-
ating characteristic (HSROC) model that assumed accuracy and
thresholds vary between studies (Rutter 2001). Analyses were con-
ducted in SAS using the NLMIXED procedure (version 9.4, SAS
Institute, Cary, NC, USA).
Investigations of heterogeneity
We assessed heterogeneity by examining forest plots of sensitivity
and specificity across studies for variability of study estimates and
overlap of the 95% CI.
Threshold (cut-off) values
We examined the effect of using different threshold (cut-off ) lev-
els of serum CRP to define a positive index test in studies. We
expected most studies to use a value between 5 mg/L and 10 mg/
L to define a positive test result but that some may have used
higher or lower levels. We investigated the effect of studies report-
ing different thresholds using meta-regression analyses (with a cat-
egorical covariate: standard threshold 5 mg/L to 10 mg/L versus
any other threshold). We assessed the effect of studies reporting a
predefined threshold (categorical covariate: reporting predefined
threshold versus not reporting predefined threshold).
Other possible sources of heterogeneity
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We planned to examine the effect of population subgroups in
meta-regression analyses (including categories as additional co-
variates). If there were sufficient data, we hoped to provide sum-
mary estimates for each subgroup and assess the statistical sig-
nificance of differences between these subgroups: gestational age
at birth (term, preterm, and very preterm infants), pathogens or
putative pathogens (coagulase-negative staphylococci, Gram-neg-
ative bacilli, S aureus, enterococci, fungi), and subtypes of late-
onset infection (CLABSI versus non-CLABSI).
Sensitivity analyses
If sufficient data were available, we planned to explore whether
study methodological quality affected the results by removing
studies considered at higher risk of bias across key domains (selec-
tion, verification).
Post hoc, we removed one study using a very high threshold (con-
sidered an outlier) in sensitivity analyses to investigate the impact
on estimates.
Assessment of reporting bias
We assessed publication bias using funnel plots (the natural loga-
rithm of the diagnostic odds ratio by 1/effective sample size) and
Deeks’ test in Stata 13 using the midas commands (Deeks 2005).
R E S U L T S
Results of the search
The flow of studies through the review process is illustrated in
Figure 1.
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Figure 1. Study flow diagram.
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We identified 9800 records in our electronic database searches up
to September 2017. We excluded 9653 of these on screening the
title and abstract. We screened the full text of 147 reports of 131
studies and excluded 111 of these (see Characteristics of excluded
studies table).
We included 20 studies reported in 20 papers (total number of
studied infants: 1615). Studies were published between 1990 and
2015 with most (15/20) published since 2000. Two studies were
cohorts assembled retrospectively (Doellner 1998; Fendler 2008);
the remaining 18 studies included prospectively observed cohorts.
Most studies (16/20) were carried out in high-income countries
in Europe (Bohnhorst 2012; Decembrino 2015; Doellner 1998;
Fendler 2008; Jacquot 2009; Kipfmueller 2015; Kordek 2014;
Verboon-Maciolek 2006), Asia (Chan 1997; Ng 1997; Choo
2012), North America (Benitz 1998; Pynn 2015), South America
(Bustos 2012), or Australasia (Seibert 1990; Sherwin 2008). Four
studies were conducted in low- and middle-income countries (
Aminullah 2001; Boo 2008; Kumar 2010; Hisamuddin 2015).
All but one of the studies were single-centre investigations. Benitz
1998 was a three-centre study.
Sample sizes ranged from 11 to 184 infants. Four studies had
a sample size of 25 or fewer (Doellner 1998; Aminullah 2001;
Choo 2012; Kipfmueller 2015). Nine studies included between
40 and 100 infants (Verboon-Maciolek 2006; Boo 2008; Fendler
2008; Sherwin 2008; Jacquot 2009; Bustos 2012; Kordek 2014;
Decembrino 2015; Hisamuddin 2015). Seven studies had sample
sizes of 100 or more infants (Seibert 1990; Chan 1997; Ng 1997;
Benitz 1998; Kumar 2010; Bohnhorst 2012; Pynn 2015).
In 16 studies, participants were preterm (or very low birth weight)
infants predominantly. Four studies did not report the gestational
age range of the included infants but it is likely that most partici-
pants were preterm or low birth weight (Aminullah 2001; Kumar
2010; Decembrino 2015; Hisamuddin 2015).
Twelve studies only investigated infants with late-onset infec-
tion (Seibert 1990; Ng 1997; Doellner 1998; Aminullah 2001;
Verboon-Maciolek 2006; Fendler 2008; Sherwin 2008; Jacquot
2009; Bohnhorst 2012; Kordek 2014; Kipfmueller 2015; Pynn
2015). The remaining studies included infants with early-onset
and late-onset infection. We were able to extract data on infants
with late-onset infection (or have these data provided by the pri-
mary investigators).
Where reported, most studies (9/12) defined late-onset as occur-
ring more than 72 hours after birth, but across studies the defi-
nition ranged from 48 hours to six days after birth. We included
these studies as this is consistent with the range of definitions that
exist in clinical practice and research (Dong 2015).
Fourteen studies used a prespecified threshold of serum CRP level
to determine the threshold level (cut-off ) for a positive test. These
thresholds ranged from 1mg/L to 12 mg/L with most studies (12/
14) using a cut-off level between 5mg/L and 10mg/L. None of the
studies reported sensitivity and specificity at multiple thresholds.
Six studies determined the CRP threshold level retrospectively
(by modelling the area under the receiver operating curve). These
studies determined the following thresholds:
• Fendler 2008: 2.2 mg/L;
• Decembrino 2015: 6 mg/L;
• Benitz 1998: 10 mg/L;
• Verboon-Maciolek 2006: 14 mg/L;
• Sherwin 2008: 18 mg/L;
• Bustos 2012: 111 mg/L.
Methodological quality of included studies
Participant selection
1. Risk of bias
The included studies were at low risk of participant selection bias.
While the details of the recruitment process were not always re-
ported, we judged that, on the whole, studies avoided inappro-
priate exclusions. We specified in our protocol that case-control
studies would be excluded from the review as this design would
not have been appropriate for the review question.
2. Concerns regarding applicability
Based on the information reported, we judged that the participants
and the setting of the included studieswere applicable to our review
question.
Index test
1. Risk of bias
Overall, the risk that the conduct or interpretation of the index
test (serum CRP level) could have introduced bias was low. The
serum CRP level was measured in infants presenting with clinical
features of late-onset infection before the results of the reference
standard were known. Most (14/20) studies prespecified threshold
of CRP level consistent with current clinical practice (1 mg/L to
12 mg/L). The other studies determined the optimal threshold
post hoc but, with the exception of one outlier (Bustos 2012), this
threshold was similar to the range used in studies that prespecified
the threshold (2 mg/L to 18 mg/L).
Two studies were at unclear risk that the conduct or interpretation
of the index test (serum CRP level) could have introduced bias as
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we were unable to determine whether or not the index test results
were interpreted without knowledge of the reference standard (
Benitz 1998; Boo 2008). In one study, the risk of bias introduced
by the conduct of the index test was high because the outcome
of the reference standard (blood culture) was known before the
interpretation of the CRP level (Fendler 2008).
2. Concerns regarding applicability
Across all studies, the index test, its conduct, and its interpretation
were applicable to our review question. While there was expected
variation in clinical practice between studies, we did not deem
this to be of a magnitude that would cause concerns regarding
applicability.
Reference standard
1. Risk of bias
As per our inclusion criteria, all studies used microbiological
culture of a potential pathogen from blood or a normally ster-
ile body fluid as the reference standard for late-onset infection.
Twelve studies reported some description of the infecting micro-
organisms (Chan 1997; Ng 1997; Benitz 1998; Aminullah 2001;
Verboon-Maciolek 2006; Boo 2008; Fendler 2008; Sherwin 2008;
Jacquot 2009; Bohnhorst 2012; Bustos 2012; Pynn 2015). These
included coagulase-negative staphylococci (typically representing
about 50% of the total cases), S aureus, enterococci, Streptococcus
agalacticae, Gram-negative bacillia, and fungi (typically Candida
spp.).
Four studies included a clinical and radiological diagnosis of pneu-
monia within the case definition for the reference standard (Ng
1997; Benitz 1998; Doellner 1998; Sherwin 2008). Two of these
studies reportedno cases of pneumonia (Ng 1997;Doellner 1998).
The other studies reported one (Benitz 1998) and two (Sherwin
2008) cases of pneumonia and it was unclear whether these infants
had a concordant positive microbiological culture from blood or
a normally sterile body fluid. We did not consider this deviation
from the reference standard definition as a sufficient source of bias
to justify excluding the studies. In one study, “urinary sepsis” was
eligible for inclusion in case definition, but no episodes of urinary
tract infection were reported (Kumar 2010).
We excluded all studies in which the index test (CRP level) was
part of the reference standard, that is, those in which a raised CRP
level and a positive blood culture was needed for a formal diagnosis
of infection. As such, across the included studies, there was a low
risk that the reference standard, its conduct, or its interpretation
could have introduced bias.
2. Concerns regarding applicability
In all studies, the condition under investigation was infection in
newborn infants. Across the included studies, there was some vari-
ation with regards to the babies’ ages at the time of first clinical
suspicion of sepsis and their gestational age. However, through
contact with authors, we were able to obtain data for only those
babies with late-onset infection, even for those studies that also in-
cluded younger infants with early-onset infection. We were confi-
dent that the target condition investigated in the included studies
matched our review question.
Flow and timing
1. Risk of bias
All studies used blood samples taken at the initial investigation of
each infant to determine the serum CRP level and for the blood
culture. Due to the nature of the reference standard, the blood
culture results followed 24 to 48 hours after the index test, de-
pending on laboratory procedure. Across all studies, there was a
low risk that the patient flow might have introduced bias.
Overall risk of bias
The methodological quality of the included studies was good and
the risk of bias minimal (Figure 2).
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Figure 2. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study.
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Findings
See Figure 3 for the summary receiver operating curve and Figure
4 for forest plots.
Figure 3. Summary receiver operating characteristic (SROC) plot of C-reactive protein for neonatal
infection. Study estimates of sensitivity and specificity are shown with the SROC curve.
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Figure 4. Forest plot: sensitivity and specificity of C-reactive protein for diagnosing late-onset infection.
We calculated estimates of sensitivity at fixed values of specificity
(median, lower and upper quartiles reported in the included stud-
ies) on the SROC curve. At median reported specificity (0.74),
sensitivity was 0.62 (95% CI 0.50 to 0.73); at the lower quartile
reported specificity (0.61), sensitivity was 0.76 (95% CI 0.65 to
0.84); at the upper quartile reported specificity (0.85), sensitivity
was 0.44 (95% CI 0.32 to 0.57). GRADE quality of evidence was
moderate, downgraded from high for inconsistency (Summary of
findings).
We used these data for sensitivity (0.62) and median reported
specificity (0.74) to estimate post-test probabilities after a ’positive’
or ’negative’ CRP test for a range of pretest probabilities in infants
being evaluated for possible late-onset infection and receiving a
CRP test (Table 2).
The prevalence of late-onset infection in the included studies
ranged from 20% to 82% (median 40%, interquartile range 27%
to 61%). We applied the diagnostic test accuracy estimates for
sensitivity (0.62) and median specificity (0.74) from our meta-
analysis to a hypothetical cohort of 1000 neonates with a preva-
lence of infection of 20%, 40%, or 60%:
• 20%: on average, 76 cases of infection would be missed and
208 would be wrongly diagnosed with infection;
• 40%: 152 cases of infection would be missed and 156
wrongly diagnosed with infection;
• 60%: 228 cases would be missed and 104 wrongly
diagnosed with infection.
Investigation of heterogeneity and sensitivity analyses
It was not possible to conduct any subgroup or meta-regression
analyses by gestational age (most participants were preterm infants
of a range of gestational ages; some studies included term infants,
but subgroup data were not available), subtypes of late-onset in-
fection (most studies did not report CLABSI or other subtypes of
late-onset infection), or types of pathogen or putative pathogen
(studies included a range of pathogens, but subgroup data were
generally not available).
Threshold values
We examined the effect of using different threshold (cut-off ) levels
of serumCRP to define a positive index test in studies. All but one
of the studies used a serum CRP level threshold between 1 mg/
L and 18 mg/L, whether predefined or determined post-hoc (see
below), to define a positive test result. Most studies (13/20) used
a threshold between 5 mg/L and 10 mg/L.
When covariates on thresholds above or below 5mg/L to 10 mg/L
were added, likelihood ratio tests found no statistically significant
difference in goodness of fit for any of these models compared
with those without covariates.
Reporting a predefined threshold versus not reporting a
predefined threshold
Six studies did not report using apredefined threshold. Of these,
four studies did not report a standard threshold. There were no
statistically significant differences in goodness of fit between any
of these models including a covariate for predefined threshold
compared with models without covariates.
Sensitivity analyses
One study was an outlier and reported using a cut-off level of 111
mg/L (Bustos 2012). Removing the study had limited impact on
effect estimates. At median specificity reported in the included
studies (0.72), sensitivity was 0.65 (95% CI 0.53 to 0.75); at the
lower quartile for specificity (0.60) sensitivity was 0.76 (95% CI
0.65 to 0.84); at the upper quartile for specificity (0.84) sensitivity
was 0.48 (95% CI 0.36 to 0.60).
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Publication bias
We assessed publication bias using a funnel plot and Deeks test
(Deeks 2005). Visual assessment of the funnel plot did not identify
important asymmetry and was not statistically significant (Figure
5).
Figure 5. Deeks’ Funnel Plot Asymmetry Test.
D I S C U S S I O N
Summary of main results
We identified 20 cohort studies reporting the test accuracy of
serum CRP for diagnosing late-onset infection in newborn in-
fants. We calculated sensitivity (0.62, 95% CI 0.50 to 0.71) at the
median specificity reported in our included studies (0.74). The
analyses demonstrated inconsistency, that is, heterogeneity in the
estimates of sensitivity and specificity.However, because of limited
data availability, we were unable to explore whether the source of
this variation was due to between-study differences in the pop-
ulation of infants (preterm versus term infants), the subtypes of
infection (such as CLABSI), or the infecting micro-organisms.
Applying these data to a hypothetical cohort of 1000 newborn
infants being evaluated for possible late-onset infection, we esti-
mated that, if the prevalence of true infection was 40% (the me-
dian prevalence in the included studies), then, on average, 152
cases of infection would bemissed (false negative) and 156 non-in-
fected infants would be wrongly diagnosed (false positive). There-
fore, serum CRP levels are unlikely to be considered sufficiently
accurate as a triage test to select infants for further tests or inter-
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ventions. These findings are similar to those in a systematic review
and meta-analysis of the accuracy of elevated serum CRP levels
for diagnosing serious infection in children (aged one month to
18 years) with febrile illness (Van den Bruel 2011).
Strengths and weaknesses of the review
Index test
The serum CRP threshold level for a ’positive’ test used in the
included studies was typically between 5 mg/L and 10 mg/L, con-
sistent with current use in clinical practice. In most studies, the
threshold was defined a priori, and the estimates of test perfor-
mance based on this predefined cut-off for a positive test. Six stud-
ies did not predefine a threshold for positivity. The investigators
performed post hoc analyses to determine the optimal cut-off for
test performance, that is, the level of serum CRP that maximised
the area under the receiver operator curve. Five of these studies
calculated levels between 2.2 mg/L and 18 mg/L (with two studies
finding optimal cut-offs between 5mg/L and 10mg/L).One study
was an outlier with an optimal cut-off of 111 mg/L (confirmed
with primary investigator). Neither the published study nor any
unpublished data we received from the authors explained this un-
expectedly high cut-off. However, in a sensitivity analysis without
this study, there was not a substantial impact on estimates of sen-
sitivity at median, upper, or lower quartiles of specificity reported
in the included studies.
Reference standard
Our reference standard was microbiologically confirmed late-on-
set infection (more than 72 hours after birth) including bacter-
aemia, fungaemia, meningitis, osteomyelitis, septic arthritis, and
peritonitis. The definition of late-onset infection used in the in-
cluded studies varied. Some studies additionally included urinary
tract infection or radiologically confirmed pneumoniawithin their
case definition. These studies typically had none or very few par-
ticipants with these diagnoses in the absence of bacteraemia, and
we made a consensus decision to include their data rather than to
exclude the full study.
Similarly, we accepted the primary study authors’ definition of
late-onset infection with regards to the infant’s age when evaluated.
Definitions ranged from48hours to six days after birth.While this
is a deviation from our proposed definition of more than 72 hours
after birth, we made a pragmatic consensus decision to include
studies in order to reflect the available evidence as well as variation
in the precise definition of ’late-onset’ that exists in clinical practice
(Haque 2005).
While variations in case-definition may have contributed to dif-
ferences in the rates of confirmed infection in studied cohorts, it is
likely that between-study differences in thresholds for investigat-
ing suspected infection are also important factors. We were unable
to explore this possibility as we had insufficient data to determine
how eligibility for inclusion criteria were applied in practice. Stud-
ies of diagnostic test accuracy in this context typically accept that
variation in clinical decisions exists. However, though potentially
contributing to heterogeneity in estimates of test performance,
this pragmatic approach may make study findings more generally
applicable.
There are concerns about how fully the reference standard de-
fines all of those infants who truly have bloodstream infection.
Microbiological cultures may not detect cases of bacteraemia or
fungaemia if an insufficient volume of the infant’s blood is incu-
bated (’false negative’). Conversely, microbiological cultures may
also generate ’false positive’ results if blood sampling techniques
allow entry of contaminating micro-organisms (typically coagu-
lase-negative staphylococci from the infant’s skin) (Oeser 2013).
Insufficient data were available to undertake a subgroup analysis of
infection with coagulase-negative staphylococci versus other bac-
teria to explore whether test accuracy was affected by the likeli-
hood of identifiedmicro-organisms representing true bloodstream
infections. However, any such analysis may be confounded by be-
tween-species differences in the capacity of micro-organisms to
trigger inflammatory cascades and generation of CRP.
Since these potential sources of verification bias may affect esti-
mates of test performance, some studies required additional evi-
dence of infection (usually clinical signs such as episodes of ap-
noea or temperature instability) for infants to meet the reference
standard. However, some studies used a reference standard that
incorporated the index test, that is, the serum CRP level was part
of the definition of ’infection’ in addition to microbiological cul-
ture of a pathogen from blood or a normally sterile body fluid.
We excluded these studies because of their risk of bias; index test
accuracy would be overestimated if the reference standard could
only be met by infants with an elevated serum CRP level.
Search strategy
We undertook a comprehensive literature search for studies us-
ing a strategy designed by an information specialist. We did not
use ’study type’ filters as these increase the risk of relevant studies
being missed due to inconsistent indexing in electronic databases
(Wilczynski 2007). As with systematic reviews of interventional
studies, publication bias may exist if studies which did not indicate
good test performance were not submitted or accepted for publi-
cation (Leeflang 2014). Visual assessment of the funnel plot iden-
tified no important asymmetry and was not statistically significant
(P = 0.1) and may indicate heterogeneity rather than publication
bias.
We contacted study authors to obtainmissing or unpublisheddata.
While several authors provided additional information, many did
not and this resulted in the exclusion of studies that might have
been eligible for inclusion. We excluded 39 studies due to insuf-
ficient data. Similarly, we excluded four studies published in lan-
guages other than English as we did not have the resources to ob-
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tain a reliable translation.
We employed review methods to reduce the risk of reviewer error
and bias, including independent and duplicate study selection as
well as checking of data extraction and risk of bias assessments. We
assessed the risk of bias of included studies using the QUADAS-
2 tool. Overall, studies were at low risk of bias but some use of
the ’unclear’ category was unavoidable due to missing detail in
study reports. We excluded case-control studies as this design is
unlikely to allow valid assessment of diagnostic test accuracy in this
clinical context. As described above, we excluded studies at high
risk of incorporation bias (serum CRP level part of the reference
standard) as these studies overestimate test performance. The only
’high’ risk of bias was identified in a retrospective study in which
the result of the reference standard was known before the index
test was performed (although the laboratory test result was not
likely to have been affected by this knowledge).
Heterogeneity
Heterogeneity is a well-recognised feature in reviews of diagnostic
test accuracy (Reitsma 2005). We observed between-study varia-
tion in the estimates of sensitivity and specificity in the forest plot
(Figure 3). We have not determined the degree to which this het-
erogeneity exceeded that expected due to chance (Naaktgeboren
2016). Our study selection, data extraction, and assessment of
study quality was limited by missing details on procedures and in-
fant characteristics, such as gestational age, blood sampling tech-
niques, and methods used to determine the serum CRP level. Be-
cause of these data limitations, we were unable to explore sources
of heterogeneity by subgroup analyses by gestational age (term
versus preterm infants), type of infection (CLABSI versus other
infections), type of infecting organism (coagulase-negative staphy-
lococci versus other pathogens), or type of laboratory technique
used to measure serum CRP levels (high-sensitivity CRP versus
standard methods).
Setting
Most included studies assessed the accuracy of elevated serumCRP
levels for diagnosing late-onset infection in preterm infants in
neonatal units in high- or middle-income countries. While these
data are likely to be applicable to preterm infants cared for in mod-
ern neonatal units in high- and (some) middle-income countries,
the review findings are less likely to be generalised to resource-lim-
ited settings in low- or middle-income countries where late-on-
set infection in newborn infants differs with regard to epidemiol-
ogy, microbiology, pathogenesis, treatment options, and outcomes
(Vergnano 2005; Zea-Vera 2015).
Applicability of findings to the review question
The review findings are specific to the accuracy of the serum CRP
level in determining whether infection is less or more likely in
infants inwhom there is a clinical suspicionbased on signs for other
findings. The review does not address whether serial monitoring
of the serum CRP level may be useful in screening well neonates
for infection before it is suspected clinically, or in assessing the
response to treatment, including helping to decide whether to stop
antibiotics (Ehl 1997).
The timely diagnosis of late-onset infection based on clinical fea-
tures and signs in newborn infants, particularly very preterm in-
fants, remains challenging (Verstraete 2015). This analysis suggests
that the serum CRP level as an adjunctive triage test for late-onset
infection is not sufficiently accurate to determine which infants
should receive treatment with antimicrobial agents or further tests.
Applying the likelihood ratios derived from the meta-analyses to a
hypothetical cohort of infants with suspected late-onset infection
indicates that the test would generate a substantial number of both
false-negative and false-positive results across a range of plausible
prevalences (see Table 2 for post-test probabilities across range of
pretest probabilities). For example, if the estimated pretest prob-
ability of infection for a given infant was 40% (the median for
the included studies), then adding in the serum CRP level to the
assessment would generate a post-test probability of 26% for a
negative test (does not ’rule out’ infection) and a post-test proba-
bility of 61% for a positive test (does not ’rule in’ infection).
This suboptimal diagnostic performance of serum CRP is consis-
tent with estimates of its accuracy in other contexts including for
diagnosing serious infection in children (aged one month to 18
years) with febrile illness (Van den Bruel 2011). The possible ex-
planations for this lack of diagnostic accuracy include the potential
for false-positive results if CRP levels are elevated by triggers such
as inflammation due to extravasation, cholestasis, or gastrointesti-
nal pathology (Hofer 2013). Conversely, serum CRP levels may
not rise, or rise only slowly, in some infected infants, particularly
very preterm infants with coagulase-negative staphylococcal bac-
teraemia (false-negative results) (Lai 2015; Gilfillan 2017).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The serum C-reactive protein (CRP) level at initial evaluation of
an infant with suspected late-onset infection does not aid early
diagnosis and is not likely to be considered a sufficiently accurate
test to select infants who would undergo further investigation or
be treated with antimicrobial therapy or other interventions.
Implications for research
Given the poor performance of serum CRP in this context, re-
search efforts might focus on other serum biomarkers, such as
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procalcitonin, that are elevated more quickly in response to in-
fection or inflammation (Gilfillan 2017). Newer methods using
molecular markers to identify pathogenic micro-organisms (such
as real-time polymerase chain reaction or microarray techniques)
are worthy of further research. These new techniques can provide
results more quickly than standard microbiological culture (six to
eight hours versus 24 to 36 hours), and evidence of their diagnos-
tic accuracy is accumulating (Pammi 2017).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Aminullah 2001
Study characteristics
Patient sampling Prospective investigation of newborn infants (birth weight > 1 kg) with suspected late-onset (> 72
hours) infection
Patient characteristics and set-
ting
Newborn infants with birth weight > 1 kg (gestational age range not reported) in 1 neonatal unit
in Indonesia
Index tests Serum CRP level > 12 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Serum CRP measured at initial evaluation, reference standard determined over 24-48 hours subse-
quently
Comparative
Notes 1999
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Aminullah 2001 (Continued)
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Benitz 1998
Study characteristics
Patient sampling Prospective evaluation of all infants with suspected infection
Patient characteristics and set-
ting
Newborn infants (mean gestational age at birth 32 weeks), 3 NICU in USA
Index tests Serum CRP level > 10 mg/L
Target condition and reference
standard(s)
Suspected or confirmed (microbiological culture of blood, CSF, or joint aspiration) late-onset in-
fection (“without consideration of CRP levels”)
Flow and timing Serum CRP measured at initial evaluation, reference standard determined over 24-48 hours subse-
quently
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Benitz 1998 (Continued)
Comparative
Notes The study included ’pneumonia’ within the reference standard definition, but the investigators
reported only 1 case of pneumonia in the entire study cohort
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
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Benitz 1998 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Bohnhorst 2012
Study characteristics
Patient sampling Prospective evaluation of all neonates (term and preterm) with suspected infection after day 4
Patient characteristics and set-
ting
Newborn infants (mean gestational age at birth 28 weeks), 1 NICU in Germany
Index tests Serum CRP level > 10 mg/L (defined a priori)
Target condition and reference
standard(s)
Unclear if index test (serumCRP level) informed decisions to performmore tests (e.g. CSF sampling
and culture) or diagnosis of ’suspected’ infection if blood was negative
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes Uncertain whether knowledge of initial serum CRP level affected care and investigation pathway
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Bohnhorst 2012 (Continued)
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Boo 2008
Study characteristics
Patient sampling Prospective evaluation of newborn infants with suspected infection; not stated if consecutive or
randomly sampled cohort
34C-reactive protein for diagnosing late-onset infection in newborn infants (Review)
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Boo 2008 (Continued)
Patient characteristics and set-
ting
Newborn infants (median gestation at birth 32 weeks) with suspected infection after day 2, NICU
in Malaysia
(1/18 infants evaluated on day 1 after birth)
Index tests Serum CRP level > 1 mg/L (defined a priori)*
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes *The unit for measuring serum CRP level was ’mg/mL’ in the report but this was confirmed by the
investigators to be a typographical error and should have been mg/L
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
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Boo 2008 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Bustos 2012
Study characteristics
Patient sampling Prospective evaluation of newborn infants with suspected infection; not stated if consecutive or
randomly sampled cohort
Patient characteristics and set-
ting
Neonates with clinically suspected late-onset sepsis (gestational age 23-35 weeks) in 1 NICU in
Chile
Index tests Serum CRP level > 111 mg/L (calculated post hoc)
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes
Methodological quality
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Bustos 2012 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Bustos 2012 (Continued)
Were all patients included in the
analysis?
Yes
Low
Chan 1997
Study characteristics
Patient sampling Prospective sample of VLBW infants; unclear whether randomly selected
Patient characteristics and set-
ting
VLBW infants (mean gestation at birth 28 weeks) with suspected infection after day 3, 1 NICU in
Singapore
Index tests Serum CRP > 10 mg/L (defined a priori)
Target condition and reference
standard(s)
Infection confirmed by blood, CSF, or joint aspiration microbiological culture
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Yes
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Chan 1997 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Choo 2012
Study characteristics
Patient sampling Prospective cohort of neonates (unclear whether consecutive or random sample)
Patient characteristics and set-
ting
Newborn infants (> 29 weeks’ gestation at birth) in 1 NICU in Korea
Index tests Serum CRP > 10 mg/L (defined a priori)
Target condition and reference
standard(s)
Blood culture-confirmed infection
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Choo 2012 (Continued)
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes We thank the investigators for providing data for infants with suspected late-onset infection
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
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Choo 2012 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Decembrino 2015
Study characteristics
Patient sampling Prospective cohort of infants (consecutive enrolment)
Patient characteristics and set-
ting
Infants in 1 NICU in Italy (gestational age or age at study entry not reported)
Index tests Serum CRP level > 6 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes We thank Dr Decembrino for providing unpublished data.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Decembrino 2015 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Doellner 1998
Study characteristics
Patient sampling Retrospective cohort study of newborn infants with suspected late-onset (> 48 hours) infection
during first week after birth
Patient characteristics and set-
ting
Newborn infants (mean gestation 38 weeks) admitted to 1 NICU in Norway
Index tests Serum CRP level > 10 mg/L
Target condition and reference
standard(s)
Neonatal infection confirmed by positive blood culture (some infants may have had an additional
diagnosis of pneumonia*)
Flow and timing Blood samples for CRP and blood culture were taken at the same time, blood culture result available
over 24-48 hours
Comparative
Notes The study authors provided additional information for construction of 2×2 tables for infants with
late-onset (> 48 hours) infection
(*The authors were unable to clarify how many infants who met the reference standard had pneu-
monia.)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
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Doellner 1998 (Continued)
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Fendler 2008
Study characteristics
Patient sampling Retrospective analysis of preterm neonates treated for suspected late-onset infection
Patient characteristics and set-
ting
Preterm infants (median gestational age 29 weeks) with suspected late-onset infection who had all
investigations (biomarkers and blood culture) assessed at the same time in 1 NICU in Poland
Index tests Serum CRP level. Threshold of 2.2 mg/L determined retrospectively with Youden method on an
ROC curve
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
44C-reactive protein for diagnosing late-onset infection in newborn infants (Review)
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Fendler 2008 (Continued)
Notes Data from 5 eligible infants not available for analysis.
Further data provided by primary investigators.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Unclear Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
No
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
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Fendler 2008 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Hisamuddin 2015
Study characteristics
Patient sampling Prospective study of consecutive infants with suspected sepsis*
Patient characteristics and set-
ting
Infants (birth weight > 1500 g, gestational age > 32 weeks) with suspected sepsis in 1 NICU in
Pakistan
Index tests Serum CRP level > 5 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes * This study included both infants with early-onset sepsis (0-5 days after birth) and infants with
late-onset sepsis (≥ 6 days after birth). The authors provided unpublished data on infants aged > 6
days
We thank Dr Hisam for providing unpublished data.
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Hisamuddin 2015 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Jacquot 2009
Study characteristics
Patient sampling Prospective study of all newborn infants with clinical suspicion of late-onset infection
Patient characteristics and set-
ting
Neonates (median gestation 28 weeks) evaluated for suspected infection, 1 NICU in France
Index tests Serum CRP level > 10 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection*
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes *29/30 infants had blood culture confirmed infection, and 1 infant was classified as infection based
on clinical features but without microbiological confirmation
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
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Jacquot 2009 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Kipfmueller 2015
Study characteristics
Patient sampling Prospective study of VLBW infants with suspected late-onset infection
Patient characteristics and set-
ting
VLBW infants (mean gestational age 28 weeks) in 1 NICU in Germany
Index tests Serum CRP level > 10 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes Non-infected group consisted of infants with clinical suspicion of infection without a positive blood
culture. 1 indicator of ’clinical suspicion’ was detection of a serum CRP level > 10 mg/L
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Kipfmueller 2015 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Kipfmueller 2015 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Kordek 2014
Study characteristics
Patient sampling Prospective study of all newborn infants with clinical suspicion of late-onset infection
Patient characteristics and set-
ting
Newborn infants (median gestational age 30 weeks) in 1 NICU in Poland
Index tests Serum CRP level > 5 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test All tests
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Kordek 2014 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Kumar 2010
Study characteristics
Patient sampling Prospective investigation of newborn infants evaluated for possible late-onset infection
Patient characteristics and set-
ting
Newborn infants (gestational age range not described) in 1 NICU in Kenya
Index tests Serum CRP level > 5 mg/L
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Kumar 2010 (Continued)
Target condition and reference
standard(s)
Blood or CSF culture-confirmed infection (plus urine culture*)
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes *Urinary sepsis was eligible for inclusion in case definition, but no episodes of urine infection were
reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
Yes
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Kumar 2010 (Continued)
of the results of the index tests?
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Ng 1997
Study characteristics
Patient sampling Prospective study of all VLBW infants evaluated for possible late-onset infection
Patient characteristics and set-
ting
VLBW infants (mean gestational age 30 weeks) in 1 NICU in Hong Kong
Index tests Serum CRP level > 10 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection*
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes *Radiologically diagnosed pneumonia was eligible for inclusion in case definition, but no episodes
of pneumonia were reported
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Ng 1997 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
55C-reactive protein for diagnosing late-onset infection in newborn infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pynn 2015
Study characteristics
Patient sampling Prospective observational study of neonates with suspected late-onset infection
Patient characteristics and set-
ting
Newborn infants (median gestation 28 weeks) in 1 NICU in USA
Index tests Serum CRP level > 10 mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection*
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes *Definition of coagulase-negative staphylococcal bacteraemia required 2 positive blood cultures
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
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Pynn 2015 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Seibert 1990
Study characteristics
Patient sampling Prospective study of very preterm infants evaluated for suspected late-onset (> 72 hours) infection
Patient characteristics and set-
ting
Very preterm newborn infants (23-31 weeks’ gestation) in 1 NICU in Australia
Index tests Serum CRP level > 10mg/L
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes
Methodological quality
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Seibert 1990 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
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Seibert 1990 (Continued)
Were all patients included in the
analysis?
Yes
Low
Sherwin 2008
Study characteristics
Patient sampling Prospective cohort study of neonates with suspected late-onset infection
Patient characteristics and set-
ting
Neonates (23-42 weeks’ gestation) in 1 NICU in New Zealand
Index tests Serum CRP level > 18 mg/L* determined retrospectively with reference to ROC curve
Target condition and reference
standard(s)
Blood culture-confirmed infection**
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes *Presumed typographical error in table describing sensitivity and specificity; threshold reported in
pg/mL, rather than mg/L
**2/117 participating infants were diagnosed with pneumonia; unclear from the published data
whether these infants had suspected late- or early-onset sepsis and whether or not they had a positive
blood culture
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
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Sherwin 2008 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Verboon-Maciolek 2006
Study characteristics
Patient sampling Prospective cohort study of infants with suspected late-onset infection
Patient characteristics and set-
ting
Preterm neonates (median gestation 29 weeks) in 1 NICU in the Netherlands
Index tests Serum CRP level > 14 mg/L determined retrospectively with reference to ROC curve
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Verboon-Maciolek 2006 (Continued)
Target condition and reference
standard(s)
Blood culture-confirmed infection
Flow and timing Index test and reference standard samples were drawn simultaneously, blood culture result available
over 24-48 hours
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Verboon-Maciolek 2006 (Continued)
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
CRP: C-reactive protein; CSF: cerebrospinal fluid; NICU: neonatal intensive care unit; ROC: receiver operating characteristic; VLBW:
very low birth weight.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aboud 2010 Study design not eligible. Case-control study
Adhikari 1986 Insufficient data. Participants’ ages unclear, unable to decide if late-onset or early-onset sepsis was investi-
gated. Decided not to try and contact the authors due to age of study
Adib 2012 Insufficient data. Data for infants with late-onset sepsis (> 72 hours) were not reported separately. These
data were requested from the authors but not provided
Adly 2014 Insufficient data. Published data was not sufficient to assess eligibility for inclusion. Additional data were
requested from the authors but not provided
Ahmed 2005 Study design not eligible. Case-control study
Ahmed 2013 Insufficient data. Abstract only. Could not locate authors for full data
Ainbender 1982 Insufficient data. Decided not to contact the authors due to age of study
Al-Zwaini 2009 Insufficient data
Alexejew 1990 Study design not eligible. Review article
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(Continued)
Aliefendioglu 2014 Study design not eligible. Case-control study
Alt 1982 Study design not eligible. Case-control study
Amato 1984 Reference standard incorporated the index test.
Ammo 2008 Insufficient data. Abstract only. We were unable to locate the full text or contact the authors to request
further data
Ananina 1963 Insufficient data. Decided not to contact the authors due to age of study
Ang 1990 Insufficient data. Data not extractable. Could not locate authors for clarification
Anwer 2000 Population not eligible. Unclear from paper if late-onset or early-onset sepsis was investigated. We decided
not to try and contact the authors due to age of study
Apostolou 2002 Insufficient data. We decided not to contact the authors due to age of study
Arani 2013 Population not eligible. Early-onset sepsis
Arati 2014 Insufficient data to populate 2×2 table. No email address available for corresponding author
Arayici 2014 Study design not eligible. Case-control study
Arnon 2004 Population not eligible. Comparison of CRP levels in babies who died of sepsis and those who survived
Arnon 2005 Study design not eligible. Case-control study
Arnon 2007 Population not eligible. Early-onset sepsis
Athhan 2002 Insufficient data. We decided not to contact the authors due to age of study
Athiraman 2011 Insufficient data for. Could not locate authors for additional information
Ayazi 2014 Insufficient data. Published data did not allow extraction of information on infants with late-onset sepsis
only. This information was requested from the authors but not provided
Aydin 2012 Study design not eligible. Case-control study
Aydin 2013 Study design not eligible. Case-control study
Baptista-Gonzales 1989 Population not eligible. Early-onset sepsis
Baruti-Gafurri 2010 Study design not eligible. Case-control study
Batfalsky 2012 Study design not eligible. Case-control study
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(Continued)
Beceiro Mosquera 2009 Population not eligible. Early-onset sepsis
Berger 1995 Insufficient data. Could not locate authors for additional information
Berrington 2014 Other. CRP not investigated
Bhandari 2008 Other. No mention of CRP in the paper
Bhargava 2011 Study design not eligible. Case-control study
Bhargava 2013 Study design not eligible. Case-control study
Blanco 1996 Insufficient data. We decided not to contact the authors due to age of study
Blommendahl 2002 Insufficient data. We decided not to contact the authors due to age of study
Boonkasidecha 2013 Insufficient data.Data fromboth early-onset sepsis and late-onset sepsis included in the study.We contacted
authors for late-onset sepsis-only data but received no reply
Boskabadi 2010 Study design not eligible. Case-control study
Bressan 2010 Population not eligible. Participants were admitted from the community
Buck 1994 Insufficient data. We decided not to contact the authors due to age of study
Bustos Betanzo 2007 Study design not eligible. Case-control study
Catal 2014 Study design not eligible. Case-control study
Ceccon 2006 Foreign language study. The abstract published in English contained insufficient information to assess
eligibility. We contacted the authors but received no reply
Cekmez 2011 Study design not eligible. Case-control study
Celik 2010 Reference standard incorporated the index test
Celik 2012 Reference standard incorporated the index test
Cesur 2009 Study design not eligible. Case-control study
Cetinkaya 2009 The reference standard incorporated the index test
Chen 2009 Population not eligible. Participants were admitted to hospital from the community
Davis 2015 Reference standard not eligible. This study used theNEO-KISS classification (German surveillance system
for nosocomial infections in VLBW infants) as the reference standard. However, as blood culture results
are part of the NEO-KISS classification, we contacted the authors to request diagnostic data for CRP using
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blood culture results as the reference standard. We received no reply
Dhanalakshmi 2015 Published data insufficient to assess eligibility for inclusion. Additional data requested from the authors
but not provided
Dorado Moles 2007 Other. Case-control study of infants with suspected infection compared with infants with other neonatal
conditions not due to infection (respiratory distress, encephalopathy)
Duhan 2016 Insufficient data to assess eligibility and to construct 2×2 table (investigators contacted October 2017)
Edgar 1994 Insufficient data. Data for infants with late-onset sepsis (> 72 hours) were not reported separately. These
data were requested from the authors but not provided. We thank Dr Edgar for responding to our emails
and trying to find the requested data
Edgar 2010 Insufficient data. Data for infants with late-onset sepsis (> 72 hours) were not reported separately. These
data were requested from the authors but not provided. We thank Dr Edgar for responding to our emails
and trying to find the requested data
El Shimi 2017 Reference standard incorporated the index test
El-Sonbaty 2016 Insufficient data to assess eligibility and to construct 2×2 table (investigators contacted October 2017)
Enguix 2001 Study design not eligible. Case-control study
Escobar 2015 Population not eligible. Early-onset sepsis
Fattah 2017 Case-control study
Franz 1999 Reference standard incorporated the index test
Ganesan 2016 Insufficient data to assess eligibility and to construct 2×2 table (investigators contacted October 2017)
Garland 2003 Insufficient data. We decided not to contact the authors due to age of study
Goldfinch 2015 Insufficient data. Abstract only, full text not found
Gorbe 2007 Foreign language study. The abstract did not contain sufficient information for inclusion. We were unable
to reach the authors to request further data
Gura 2003 Foreign language study. Insufficient data contained in abstract. Decided not to contact the authors due to
age of study
Hegadi 2015 Insufficient data to populate 2×2 table. No email address available for corresponding author
Khair 2012 Population not eligible. Early-onset and late-onset sepsis combined. Late-onset sepsis-only data requested
from authors but not provided
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Khassawneh 2007 Insufficient data. Published data did not allow extraction of information on infants with late-onset sepsis
only. This information was requested from the authors but not provided
Kite 1988 Population not eligible. Combination of early-onset and late-onset sepsis. Unable to extract appropriate
data after feedback from authors. We thank Dr Kite for his time and effort in replying to our email and
trying to provide the requested data
Kocabas 2007 Case-control study. No data on infants who had a negative sepsis evaluation
Krauel 1987 Population not eligible. Not exclusively late-onset sepsis and mixed population. Decided not to contact
the authors due to age of study
Krediet 1992 Insufficient data. This study included infants with pneumonia but without a positive blood culture in the
’sepsis’ group. We contacted the authors to request data on infants with positive blood culture only but
received no reply
Kuster 1998 Other. Sensitivity and specificity calculations were based on CRP measurements taken before the onset on
sepsis. We decided not to try to contact the authors due to age of study
Laborada 2003 Population not eligible. Combination of early-onset and late-onset sepsis. Decided not to try and contact
authors due to age of study
Lai 2015 Insufficient data. Study did not collect diagnostic data for CRP
Liu 2016 Insufficient data to assess eligibility and to construct 2×2 table (investigators contacted October 2017)
Lu 2016 The reference standard incorporated the index test
Magudumana 2000 Insufficient data. Unable to extract appropriate data. Decided not to try and contact authors due to age of
study
Manucha 2002 All participants < 4 days old (’early-onset’ infection)
Matesanz 1980 Insufficient data. No usable data. Decided not to try and contact the authors due to age of study
Mehr 2001 Insufficient data. No usable data. Decided not to try and contact the authors due to age of study
Mustafa 2005 Population not eligible. Combination of early-onset and late-onset sepsis. Could not locate author to
request late-onset sepsis only data
Nakamura 1989 Population not eligible. Combination of early-onset and late-onset sepsis. Could not locate author to
request late-onset sepsis only data
Noto 2012 Insufficient data. Abstract only. Authors’ contact details not provided
Nuntnarumit 2002 Reference standard not eligible. The reference standard used in this paper included both positive and
negative blood culture. We were unable to locate the authors to request positive blood culture only data
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Okulu 2015 Reference standard incorporated index test
Omran 2018 Case-control study. Insufficient data to assess eligibility and to construct 2×2 table (investigators contacted
October 2017)
Park 2014 The reference standard incorporated the index test
Perez Solis 2006 Study design not eligible. Case-control study
Pourcyrous 1989 Insufficient data. Abstract only. Decided not to try and contact the authors due to age of study. Could not
locate full text
Prasad 2015 Insufficient data. Authors contacted but did not provide additional data
Qin 2017 Included only infants with early-onset sepsis (< 72 hours)
Russell 1992 The reference standard incorporated the index test
Sakha 2008 Population not eligible. Combination of late-onset and early-onset sepsis. Could not locate author to
request late-onset sepsis only data
Sarafidis 2017 Study did not use a threshold of CRP to distinguish between infants with ’high’ or ’low’ CRP
Sharma 1993 Population not eligible. Unclear how many participants had late-onset sepsis. Decided not to contact
authors due to age of study
Stein 2015 Population not eligible. Participants were admitted to hospital from the community
Topuz 2012 Foreign language paper. The abstract published in English did not contain sufficient data to assess eligibility.
We contacted the authors to request further information but received no reply
Turner 2006 Population not eligible. Combination of confirmed sepsis and clinical sepsis (without a positive blood
culture). Authors were contacted and informed us that the requested data were no longer available
Tyagi 2016 Insufficient data to assess eligibility and to construct 2×2 table (investigators contacted October 2017)
Ussat 2015 The reference standard incorporated the index test
Vazzalwar 2005 Case-control study
Wu 2013 The reference standard incorporated the index test
Yao 2016 Case-control study
Ye 2017 Case-control study
Zarkesh 2015 Population not eligible. Infants were admitted to hospital from the community
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Zhao 2015 Comparison of CRP levels before and after antibiotic treatment
CRP: C-reactive protein; VLBW: very low birth weight.
Characteristics of studies awaiting classification [ordered by study ID]
Ohlin 2010
Study characteristics
Patient sampling Prospective cohort
Patient characteristics and set-
ting
Newborn infants with suspected infection (mostly infants with early-onset infection, but some with
late-onset)
Index tests Serum C-reactive protein level > 10 mg/L
Target condition and reference
standard(s)
Microbiologically confirmed infection
Flow and timing
Comparative
Notes Awaiting data for infants with late-onset infection
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 CRP 20 1615
Test 1. CRP.
Review: C-reactive protein for diagnosing late-onset infection in newborn infants
Test: 1 CRP
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Aminullah 2001 4 1 3 3 0.57 [ 0.18, 0.90 ] 0.75 [ 0.19, 0.99 ]
Benitz 1998 33 41 20 90 0.62 [ 0.48, 0.75 ] 0.69 [ 0.60, 0.77 ]
Bohnhorst 2012 40 18 18 94 0.69 [ 0.55, 0.80 ] 0.84 [ 0.76, 0.90 ]
Boo 2008 10 7 7 62 0.59 [ 0.33, 0.82 ] 0.90 [ 0.80, 0.96 ]
Bustos 2012 3 1 22 27 0.12 [ 0.03, 0.31 ] 0.96 [ 0.82, 1.00 ]
Chan 1997 14 26 16 96 0.47 [ 0.28, 0.66 ] 0.79 [ 0.70, 0.86 ]
Choo 2012 1 2 6 3 0.14 [ 0.00, 0.58 ] 0.60 [ 0.15, 0.95 ]
Decembrino 2015 4 11 4 22 0.50 [ 0.16, 0.84 ] 0.67 [ 0.48, 0.82 ]
Doellner 1998 5 6 2 9 0.71 [ 0.29, 0.96 ] 0.60 [ 0.32, 0.84 ]
Fendler 2008 48 3 16 11 0.75 [ 0.63, 0.85 ] 0.79 [ 0.49, 0.95 ]
Hisamuddin 2015 11 9 27 9 0.29 [ 0.15, 0.46 ] 0.50 [ 0.26, 0.74 ]
Jacquot 2009 17 6 13 37 0.57 [ 0.37, 0.75 ] 0.86 [ 0.72, 0.95 ]
Kipfmueller 2015 3 3 4 15 0.43 [ 0.10, 0.82 ] 0.83 [ 0.59, 0.96 ]
Kordek 2014 23 5 11 13 0.68 [ 0.49, 0.83 ] 0.72 [ 0.47, 0.90 ]
Kumar 2010 55 60 1 26 0.98 [ 0.90, 1.00 ] 0.30 [ 0.21, 0.41 ]
Ng 1997 27 2 18 54 0.60 [ 0.44, 0.74 ] 0.96 [ 0.88, 1.00 ]
Pynn 2015 30 35 7 67 0.81 [ 0.65, 0.92 ] 0.66 [ 0.56, 0.75 ]
Seibert 1990 13 30 10 47 0.57 [ 0.34, 0.77 ] 0.61 [ 0.49, 0.72 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
(Continued . . . )
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Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Sherwin 2008 14 1 20 17 0.41 [ 0.25, 0.59 ] 0.94 [ 0.73, 1.00 ]
Verboon-Maciolek 2006 24 14 13 15 0.65 [ 0.47, 0.80 ] 0.52 [ 0.33, 0.71 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. Risk of bias and applicability items and criteria for their assessment (QUADAS-2)
Item Criteria for their assessment
Domain 1: participant selection
Describe methods of participant selection (prior testing, presentation, intended use of index test and setting)
A. Risk of bias
Was a consecutive or random sample of participants enrolled? ’Yes’ if described enrolling a consecutive or random sample of
newborns prior to discharge from hospital
’No’ if criteria for ’yes’ not achieved
’Unclear’ if the study did not describe the method of enrolment
Did the study avoid inappropriate exclusions? ’Yes’ if exclusions were detailed and review authors reached con-
sensus on the appropriateness of any exclusion
’No’ if inappropriate exclusions were reported
’Unclear’ if insufficient information was provided
Could the selection of participants have introduced bias? A judgement of low, high, or unclear risk of bias was made based
on a balanced assessment of the responses to the above signalling
questions
B. Concerns about applicability
Is there concern that the included participants did not match the
review question?
A judgement of low, high, or unclear concern about applicability
will be made based on how closely the sample matches a popula-
tion of newborn infants with suspected infection
Domain 2: index test
Describe the index test and how it was conducted and interpreted
A. Risk of bias
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Table 1. Risk of bias and applicability items and criteria for their assessment (QUADAS-2) (Continued)
Were the index test results interpreted without knowledge of the
results of the reference standard?
’Yes’ if the serum CRP level was measured before the microbial
culture result was available
’No’ if reference standard results were available to those who or-
dered or interpreted the serum CRP level
’Unclear’ if insufficient information was provided.
If a threshold was used, was it prespecified? ’Yes’ if a threshold was prespecified.
’No’ if authors selected a cut-off value based on the analysis of
data collected
’Unclear’ if insufficient information was provided.
Could the conduct or interpretation of the index test have intro-
duced bias?
A judgement of low, high, or unclear risk of bias will bemade based
on a balanced assessment of the responses to the above signalling
questions
B. Concerns about applicability
Was there concern that the index test, its conduct, or interpretation
differ from the review question?
A judgement of low, high, or unclear concern about applicability
will be made based on a balanced assessment of the information
detailed under ’index test’ description
Domain 3: reference standard
Describe the reference standard(s) and how they were conducted and interpreted
A. Risk of bias
Was the reference standard likely to correctly classify the target
condition?
’Yes’ if an appropriate reference standard (as defined in the proto-
col) was used
’No’ if an inappropriate reference standard (not defined in the
protocol) was used
’Unclear’ if the reference standard used was not clearly specified
Were the reference standard results interpretedwithout knowledge
of the results of the index test?
’Yes’ if the person undertaking the reference test did not know the
results of the microbial culture
’No’ if theCRP level results were interpretedwith prior knowledge
of the index test result
’Unclear’ if insufficient information provided.
Could the reference standard, its conduct, or its interpretation
have introduced bias?
A judgement of low, high, or unclear risk of bias was made based
on a balanced assessment of the responses to the above signalling
questions
B. Concerns about applicability
Was there concern that the target condition as defined by the
reference standard did not match the question?
A judgement of low, high, or unclear concern about applicability
was made based on setting, population, risks, prevalence???
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Table 1. Risk of bias and applicability items and criteria for their assessment (QUADAS-2) (Continued)
Domain 4: flow and timing
Describe any participants who did not receive the index test or reference standard or who were excluded from the 2×2 table (refer to
flow diagram) and describe the time interval and any interventions between index test and reference standard(s)
A. Risk of bias
Did all infants receive a reference standard? ’Yes’ if the study specifically stated that all infants received blood
culture, lumbar puncture, or other biopsy to identify infection
(including autopsy examination)
’No’ if the study only assessed suspected or probable infection (not
confirmed microbiologically)
’Unclear’ if insufficient information was provided.
Were all infants included in the analysis? ’Yes’ if the study had no withdrawals or the withdrawals were
clearly described
’No’ if the number of participants contributing to the 2×2 table
did notmatch the number of participants recruited and no reasons
for exclusions were described
’Unclear’ if information was not enough to establish the flow of
participants
Could the patient flow have introduced bias? A judgement of low, high, or unclear risk of bias was made based
on a balanced assessment of the responses to the above signalling
questions
Table 2. Post-test probabilities for late-onset infection for a sample of population prevalences
Pretest probability Post-test probability after a positive result Post-test probability after a negative result
0.2 0.37 0.11
0.3 0.51 0.18
0.4 0.61 0.26
0.5 0.70 0.34
0.6 0.78 0.44
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A P P E N D I C E S
Appendix 1. Search strategy
MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1946 to Present>
Via Ovid
1 exp Infant, Newborn/ (507086)
2 Premature Birth/ (7396)
3 (neonat$ or neo nat$).ti,ab. (204089)
4 (newborn$ or new born$ or newly born$).ti,ab. (135419)
5 (preterm or preterms or pre term or pre terms).ti,ab. (50291)
6 (preemie$ or premie or premies).ti,ab. (121)
7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (12210)
8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (26659)
9 (lbw or vlbw or elbw).ti,ab. (5938)
10 infan$.ti,ab. (345004)
11 (baby or babies).ti,ab. (54493)
12 “Intensive Care Units, Neonatal”/ (10315)
13 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 (854743)
14 C-Reactive Protein/ (32529)
15 c-reactive protein.ti,ab. (44280)
16 CRP.ti,ab. (30090)
17 Interleukin-6/ (48141)
18 IL-6.ti,ab. (71459)
19 interleukin-6.ti,ab. (35713)
20 acute phase reactant$.ti,ab. (3064)
21 Biological Markers/ (172550)
22 biomarker$.ti,ab. (113562)
23 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 (371276)
24 exp Sepsis/ (95928)
25 sepsis.ti,ab. (68288)
26 infection$.ti,ab. (1022808)
27 exp Bacterial Infections/ (745229)
28 (bacteraemia or bacteremia).ti,ab. (22257)
29 (fungaemia or fungemia).ti,ab. (1664)
30 exp Candidiasis/ (27375)
31 candidiasis.ti,ab. (12078)
32 exp Meningitis/ (48258)
33 meningitis.ti,ab. (42079)
34 Pneumonia, Bacterial/ (8792)
35 Urinary Tract Infections/ (32771)
36 Catheter-related Infections/ (2533)
37 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 (1653493)
38 13 and 23 and 37 (3447)
39 exp animals/ not humans.sh. (4037496)
40 38 not 39 (3184)
Embase via Ovid
1 exp Infant/ (898706)
2 Prematurity/ (76784)
3 (neonat$ or neo nat$).ti,ab. (253737)
4 (newborn$ or new born$ or newly born$).ti,ab. (162735)
5 (preterm or preterms or pre term or pre terms).ti,ab. (66105)
6 (preemie$ or premie or premies).ti,ab. (165)
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7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (15808)
8 (low adj3 (birthweight$ or birth weight$)).ti,ab. (31872)
9 (lbw or vlbw or elbw).ti,ab. (7572)
10 infan$.ti,ab. (406724)
11 (baby or babies).ti,ab. (71539)
12 newborn intensive care/ (22338)
13 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 (1220384)
14 C Reactive Protein/ (98704)
15 c-reactive protein.ti,ab. (59724)
16 CRP.ti,ab. (53596)
17 Interleukin 6/ (140947)
18 IL-6.ti,ab. (98082)
19 interleukin-6.ti,ab. (41784)
20 acute phase reactant$.ti,ab. (4241)
21 Biological Marker/ (150561)
22 biomarker$.ti,ab. (170601)
23 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 (472866)
24 exp Sepsis/ (181816)
25 newborn sepsis/ (4927)
26 sepsis.ti,ab. (96170)
27 infection$.ti,ab. (1249750)
28 exp Bacteremia/ (35078)
29 exp Fungemia/ (4805)
30 (bacteraemia or bacteremia).ti,ab. (27114)
31 (fungaemia or fungemia).ti,ab. (2019)
32 exp Candidiasis/ (40057)
33 candidiasis.ti,ab. (15095)
34 exp Meningitis/ (75363)
35 meningitis.ti,ab. (49821)
36 Pneumococcal meningitis/ (908)
37 Urinary Tract Infection/ (75050)
38 Catheter infection/ (11655)
39 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 (1501019)
40 13 and 23 and 39 (5912)
41 animal/ (1656079)
42 human/ (15731222)
43 41 not (41 and 42) (1247837)
44 40 not 43 (5877)
Science Citation Index via Web of Science
# 4 1,256 #3 AND #2 AND #1
Indexes=
SCI-EXPANDED Times-
pan=1900-2015
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# 3 194,557 TOPIC: (sepsis) OR TOPIC:
(“bacterial infection*”) OR
TOPIC: (bacteremia or bac-
teraemia) OR TOPIC: (fun-
gaemia or fungemia) OR
TOPIC:(candidia-
sis) OR TOPIC: (meningitis)
OR TOPIC: (“pneumococ-
cal meningitis”) OR TOPIC:
(“urinary tract infection*”)
OR TOPIC: (“catheter infec-
tion*”)
Indexes=SCI-EXPANDED
Timespan=1900-2015
# 2 241,196 TOPIC: (“c reactive protein”)
ORTOPIC: (“Interleukin 6”)
OR TOPIC: (“acute phase re-
actants”) OR TOPIC: (“bio-
logical markers”)ORTOPIC:
(biomarker*)
Indexes=SCI-EXPANDED
Timespan=1900-2015
# 1 616,040 TOPIC: ((neonat*
or neo nat* or newborn* or
new born* or newly born*)
) OR TOPIC: ((preterm or
preterms or pre term or pre
terms or preemie* or premie*
or premies)) OR TOPIC:
(“premature birth” or “prema-
ture delivery”) OR TOPIC:
(low birthweight* or “low
birth weight*”) OR TOPIC:
(lbw or vlbw or elbw) OR
TOPIC: (infant or infants or
infancy or baby or babies)OR
TOPIC: (“neonatal intensive
care”)
Indexes=SCI-EXPANDED
Timespan=1900-2015
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• On the advice of a referee, we used a hierarchical summary receiver operating characteristic model rather than the proposed
bivariate random-effects approach because included studies did not use a common cut-off.
• We included studies in which infants with urinary tract infection or radiologically confirmed pneumonia fulfilled the case
definition for late-onset infection. These studies typically had none or very few participants with these diagnoses in the absence of
bacteraemia.
• We accepted the primary study authors’ definition of late-onset infection with regards to the infant’s age when evaluated (range
from 48 hours to six days after birth).
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